Related Experiment Video
Updated: Aug 11, 2026

09:02
An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 18, 2014
Mouse models for the genetic study of tuberculosis susceptibility
Tania Di Pietrantonio1, Erwin Schurr
1McGill University Health Centre Research Institute, 1650 Cedar Ave, L11-520, Montreal, PQ, H3G 1A4, Canada.
Briefings in Functional Genomics & Proteomics
|January 20, 2006
Summary
Tuberculosis remains a global health challenge. New genomic strategies in mouse models are improving our understanding of host-pathogen interactions to develop better treatments and vaccines.
Area of Science:
- Microbiology
- Immunology
- Genomics
Background:
- Tuberculosis (TB), caused by Mycobacterium tuberculosis, affects nearly 2 billion people globally.
- Despite BCG vaccination and multidrug therapy, TB causes 2 million deaths annually.
- Understanding the complex interplay between host, pathogen, and environment is crucial for effective TB control.
Purpose of the Study:
- To review advancements in understanding the host-mycobacterial-environmental interplay in tuberculosis.
- To highlight the role of new genomic strategies in elucidating these interactions.
- To inform the development of improved tuberculosis vaccines and treatments.
Main Methods:
- Review of current literature on tuberculosis pathogenesis.
- Focus on studies utilizing genomic strategies in mouse models.
- Analysis of host-pathogen interactions and environmental factors.
Main Results:
- Genomic strategies are providing novel insights into the host-mycobacterial relationship.
- Mouse models are instrumental in dissecting complex interactions.
- Emerging data suggests a clearer picture of factors influencing TB development.
Conclusions:
- A deeper understanding of the host-mycobacterial-environmental interplay is essential for combating tuberculosis.
- Genomic approaches in preclinical models are key to identifying new therapeutic targets.
- Continued research is vital for developing next-generation antituberculosis interventions.

